3 ms·
That would be very good news indeed, if it turns out to work on anything but mice. But after reading a lot of that kind of articles over the past years, I'm st
by fauigerzigerk 15y ago
That would be very good news indeed, if it turns out to work on anything but mice.
But after reading a lot of that kind of articles over the past years, I'm starting to wonder what's wrong with mice. Whenever a new treatment is tested in mice it seems to work wonders. It makes them not just a little bit better but orders of magnitude. It's like a miracle. Mice must have an incredibly bad natural constitution. You throw them some homeopathic pill and bang you have cured cancer. You drop some genes on them, whoosh, a new human ear pops up. It's amazing :-)
- Confusion 15y agoI wonder if it could be because they are so small, that the dosage is relatively much larger. Their metabolism is much faster than ours: those larger dosages may also be needed to get any effect?
- Sandman 15y agoDon't you think the researchers would take their size and metabolism into account when determining the dosage?
- loevborg 15y agoI thought this was a very funny comment.
- Confusion 15y agoFirst you have to determine whether something works at all. Then you can try dosages. But my implied point was that mice may necessarily need relatively large dosages, because it doesn't work on them otherwise. This faster metabolism thing is nontrivial: for instance, in humans, metabolic rate is coupled to the perceived rate at which time passes.
- ericb 15y agoEthically speaking, what are the problems with testing things on human bodies with no brain if that were possible? The idea is disturbing, but is it any worse than dissection/autopsy--in other words, is the disgust a visceral reaction but nothing more? It would probably put the speed of medical advances on steroids and save a lot of lives.
- wazoox 15y agoGenetically engineered mice carrying large parts of the human immune system have been in use for years, and can be a good approximation of "human body sans brain", and much cheaper with that - an anencephalic human costs actually a lot to maintain alive.
- DasIch 15y agoThere are not that much brain dead bodies available, those that are available are used for organ donations. Do you really want to reduce the number of available organs for medical testing at such an early stage? I imagine that most of these tests fail whereas a functioning organ has a very high chance of saving a life.
- truthout 15y agoYes I do actually. One organ donator is not as important as the whole of humanity. Any other opinion is ridiculous and dangerous. An ideology that spares the weak for the whole is dangerous and a violation of natural selection.
- jessriedel 15y agoCould probably take out the organs and keep the body on a heart/lung machine for days. Would only work for testing treatments on that time scale, but it would be something.
- briggsbio 15y agoActually overall, in vivo animal testing on vaccines, antivirals, and antibiotics are typically quite predictive from animals to humans. These types of tests are not historically very predictive when moving from in vitro to in vivo animal studies, however. This is typically because the treatments and vaccines are structural and/or expression-based (exploit a bacterial surface protein and poke holes in the cell, use a virus to get into T-cells and inject genetic material to let them identify and kill polio, etc). (yes, oversimplified). But moving from cell culture to a living organism This doesnt always work out. If it does, then it's relatively easy to confirm the effect if it works in animals to humans (virus is gone/never infects, etc). So more antibiotics and vaccines fail from in vitro to in vivo than from animal to human data. In treating diseases of inflammation, rheumatic disease, pain, etc., it is generally quite predictive when moving from in vitro to in vivo animal studies (e.g. is it down-regulating inflammatory transcription factor NF-kB, or not?). But it becomes much less predictive translating endpoints from animals to humans. That's, very generally, because it is difficult to assess disease measures of improvement in inflammation in animals and translate that to humans (pain, discomfort, edema, these processes may present much differently in rats versus humans, for example). Great animal data may not mean you'll get such a strong effect in human subjects, and thus the failure rate for these drugs in clinical studies is quite high compared to vaccine and antibiotic human trials, because those vaccines were shown to be ineffective earlier in development. This was a very general explanation, to be sure, and I'll dig through my archives for some papers on this and try to add links later.
- fauigerzigerk 15y agoThat's very interesting. Do you have an idea in which of these two categories cancer treatments typically fall?
- briggsbio 15y agoThat depends on the cancer and depends on the approach (structural, genetic, or immunological). The difficulty in cancer treatment is that you're dealing with a natural biological process gone awry. It's not like viral or bacterial infections, where you're fighting something off. You're dealing with aggregations of unwanted mutations and cellular proliferation (over simplification warning). Chemotherapy is less trying to alter a process than it is dropping a bomb in the body and hoping that you kill the cancer before killing the patient. There are some incredibly effective chemotherapy agents that will never make it to market because they are just too toxic. Gene therapy approaches are making promising moves, but it is very early. There are some pretty cool structural approaches, such as protein conjugated nanotubes that lyse cancer cells under infrared light (Stanford and Oklahoma researchers), but these too are early, and for only specific tumor types. Cancer is a huge problem that takes a multifaceted, case-by-case approach. Lots of tools in the tool shed, and it's growing every year. I feel in my heart that one day in the future, cancer will be called "the biggest problem of the last generation." But there is much work to be done.
- asdkl234890 15y agoI'm starting to wonder what's wrong with mice. Whenever a new treatment is tested in mice it seems to work wonders. Mice are tiny and short lived. They have had no need to evolve a whole host of cancer and disease defense mechanism, which we as very long lived and large animals have. In fact, many cancer cures in mice are simply applications of things which humans are born with. Elephants and whales probably would be a better way to study diseases. For example, humans have one copy of an ant-tumor gene, elephants have a dozen: http://blogs.discovermagazine.com/loom/2011/02/28/the-mere-existence-of-whales/ http://blogs.discovermagazine.com/loom/2011/02/28/the-mere-e... But mice are A LOT easier to study in the lab than large long lived animals would be. Also, spectacular sounding cure + non-specialized mass publication like Time = Do not believe.